LABCORP HOLDINGS INC.
LH
72 insider filings · Latest: May 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 13 1:30 PM | Adam H SchechterDirector, President & CEO | Sale | 5,903 | $254.50 | $1.5M | 107,234(D) | View → |
| May 11, 2026 | May 11 1:51 PM | Schechter Adam H | Proposed Sale | 5,903 | $254.50 | $1.5M | — | View → |
| May 6, 2026 | May 6 2:40 PM | van der Vaart Sandra D | Proposed Sale | 6,238 | $256.76 | $1.6M | — | View → |
| Mar 27, 2026 | Mar 30 4:54 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 1,633 | $267.05 | $436.1K | 1,852.219(D) | View → |
| Mar 27, 2026 | Mar 30 4:44 PM | Jonathan C MeltzerEVP, Operations | Sale | 839 | $267.05 | $224.1K | 3,620.326(D) | View → |
| Mar 27, 2026 | Mar 27 2:40 PM | Meltzer Jonathan C | Proposed Sale | 839 | $267.05 | $224.1K | — | View → |
| Mar 3, 2026 | Mar 5 1:57 PM | Adam H SchechterDirector, President & CEO | Sale | 8,705 | $279.96 | $2.4M | 80,773(D) | View → |
| Mar 3, 2026 | Mar 3 5:23 PM | Schechter Adam H | Proposed Sale | 8,705 | $279.96 | $2.4M | — | View → |
| Feb 27, 2026 | Mar 3 3:41 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Sale | 547.54 | $284.91 | $156.0K | 2,578.947(D) | View → |
| Feb 27, 2026 | Feb 27 2:40 PM | van der Vaart Sandra D | Proposed Sale | 548 | $284.67 | $156.0K | — | View → |
| Feb 24, 2026 | Feb 26 1:25 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Sale | 1,500 | $286.31 | $429.5K | 30,106.923(D) | View → |
| Feb 24, 2026 | Feb 24 6:50 PM | Caveney Brian J | Proposed Sale | 1,500 | $286.31 | $429.5K | — | View → |
| Feb 19, 2026 | Feb 23 2:13 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Sale | 666 | $277.94 | $185.1K | 1,852.219(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Adam H SchechterDirector, President & CEO | Sale | 5,273 | $284.38 | $1.5M | 87,343(D) | View → |
| Feb 12, 2026 | Feb 13 6:11 PM | Jonathan C MeltzerEVP, Operations | Sale | 87 | $290.42 | $25.3K | 2,782.326(D) | View → |
| Feb 10, 2026 | Feb 12 8:44 PM | Jonathan C MeltzerEVP, Operations | Sale | 91 | $276.79 | $25.2K | 2,696.326(D) | View → |
| Feb 12, 2026 | Feb 12 2:49 PM | Meltzer Jonathan C | Proposed Sale | 87 | $290.42 | $25.3K | — | View → |
| Feb 11, 2026 | Feb 11 5:59 PM | Schechter Adam H | Proposed Sale | 5,273 | $284.38 | $1.5M | — | View → |
| Feb 9, 2026 | Feb 10 8:04 PM | Jonathan C MeltzerEVP, Operations | Sale | 88 | $275.53 | $24.2K | 2,869.326(D) | View → |
| Feb 10, 2026 | Feb 10 3:30 PM | Meltzer Jonathan C | Proposed Sale | 91 | $276.79 | $25.2K | — | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | Feb 13 6:19 PM | Amy B. SummyEVP, Chief Marketing Officer | Option Exercise | 230 | — | 1,304(D) | View → |
| Feb 11, 2026 | Feb 13 6:17 PM | Peter J WilkinsonSVP, Chief Accounting Officer | Option Exercise | 696 | — | 1,968(D) | View → |
| Feb 11, 2026 | Feb 13 6:16 PM | Julia Aijun WangChief Financial Officer, EVP | Option Exercise | 860 | — | 4,964(D) | View → |
| Feb 11, 2026 | Feb 13 6:15 PM | Bryan T VaughnEVP, Diagnostics | Option Exercise | 323 | — | 4,031(D) | View → |
| Feb 11, 2026 | Feb 13 6:14 PM | Der Vaart Sandra D VanEVP, Corporate Affairs | Option Exercise | 376 | — | 1,141(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Mark S SchroederEVP, Pres Diagnostics & COO | Option Exercise | 806 | — | 2,358(D) | View → |
| Feb 11, 2026 | Feb 13 6:13 PM | Adam H SchechterDirector, President & CEO | Option Exercise | 3,656 | — | 22,214(D) | View → |
| Feb 11, 2026 | Feb 13 6:12 PM | Akinbolade OyegunwaEVP, CIO & CTO | Option Exercise | 230 | — | 2,190(D) | View → |
| Feb 11, 2026 | Feb 13 6:11 PM | Jonathan C MeltzerEVP, Operations | Option Exercise | 243 | — | 2,694(D) | View → |
| Feb 11, 2026 | Feb 13 6:10 PM | Kathryn W KyleEVP, Chief Legal Officer | Option Exercise | 216 | — | 2,264(D) | View → |
| Feb 11, 2026 | Feb 13 6:09 PM | Anita Z GrahamEVP, CHRO | Option Exercise | 356 | — | 2,401(D) | View → |
| Feb 11, 2026 | Feb 13 6:08 PM | Brian J CaveneyEVP, Pres of ED, CMO & CSO | Option Exercise | 740 | — | 4,170(D) | View → |
| Feb 11, 2026 | Feb 13 6:07 PM | Megan D. BaileyEVP, Pres, Central Labs & Intl | Option Exercise | 403 | — | 2,827(D) | View → |
| Feb 11, 2026 | Feb 13 6:03 PM | Paul RothmanDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:58 PM | Kathryn E WengelDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:56 PM | Richelle P ParhamDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:55 PM | Peter M NeupertDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:53 PM | Garheng KongDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:52 PM | Kirsten Marie KliphouseDirector | Option Exercise | 897 | — | 773(D) | View → |
| Feb 11, 2026 | Feb 13 5:48 PM | Jeffrey A. DavisDirector | Option Exercise | 897 | — | 773(D) | View → |
Page 1 of 4
Next →